- Home
- PMF vs KOD Comparison
PMF vs KOD Comparison
Compare PMF & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMF
- KOD
- Stock Information
- Founded
- PMF 2001
- KOD 2009
- Country
- PMF United States
- KOD United States
- Employees
- PMF N/A
- KOD N/A
- Industry
- PMF Finance/Investors Services
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMF Finance
- KOD Health Care
- Exchange
- PMF Nasdaq
- KOD Nasdaq
- Market Cap
- PMF 209.2M
- KOD 198.4M
- IPO Year
- PMF N/A
- KOD 2018
- Fundamental
- Price
- PMF $7.71
- KOD $5.19
- Analyst Decision
- PMF
- KOD Hold
- Analyst Count
- PMF 0
- KOD 3
- Target Price
- PMF N/A
- KOD $9.00
- AVG Volume (30 Days)
- PMF 61.3K
- KOD 368.3K
- Earning Date
- PMF 01-01-0001
- KOD 08-13-2025
- Dividend Yield
- PMF 5.36%
- KOD N/A
- EPS Growth
- PMF N/A
- KOD N/A
- EPS
- PMF N/A
- KOD N/A
- Revenue
- PMF N/A
- KOD N/A
- Revenue This Year
- PMF N/A
- KOD N/A
- Revenue Next Year
- PMF N/A
- KOD N/A
- P/E Ratio
- PMF N/A
- KOD N/A
- Revenue Growth
- PMF N/A
- KOD N/A
- 52 Week Low
- PMF $7.69
- KOD $1.92
- 52 Week High
- PMF $10.56
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- PMF 33.82
- KOD 69.00
- Support Level
- PMF $7.76
- KOD $4.39
- Resistance Level
- PMF $7.92
- KOD $5.33
- Average True Range (ATR)
- PMF 0.07
- KOD 0.39
- MACD
- PMF -0.01
- KOD 0.13
- Stochastic Oscillator
- PMF 8.00
- KOD 90.86
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.